APOA-I: a possible novel biomarker for metabolic side effects in first episode schizophrenia. by Xueqin Song, Xue Li, Jinsong Gao, Jingping Zhao, Youhui Li, Xiaoduo Fan, Luxian Lv

Get full text

Age‐related changes in behavior profile in male offspring of rats treated with poly I:C‐induced maternal immune activation in early gestation by Tengfei Chen, Huadan Meng, Ni Fang, Peiling Shi, Mengxue Chen, Qing Liu, Luxian Lv, Wenqiang Li

Get full text

Disorder-specific neurodynamic features in schizophrenia inferred by neurodynamic embedded contrastive variational autoencoder model by Chaoyue Ding, Yuqing Sun, Kunchi Li, Sangma Xie, Hao Yan, Peng Li, Jun Yan, Jun Chen, Huiling Wang, Huaning Wang, Yunchun Chen, Yongfeng Yang, Luxian Lv, Hongxing Zhang, Lin Lu, Dai Zhang, Yaojing Chen, Zhanjun Zhang, Tianzi Jiang, Bing Liu

Get full text

Prediction of antipsychotic drug efficacy for schizophrenia treatment based on neural features of the resting-state functional connectome by Song Liu, Meng Wang, Weiyi Han, Anran Chen, Xuzhen Liu, Kang Liu, Xue Li, Yi Chen, Luwen Zhang, Qing Liu, Xiaoge Guo, Xiujuan Wang, Ning Kang, Yong Han, Yuanbo Li, Xi Su, Luxian Lv, Bing Liu, Wenqiang Li, Yongfeng Yang

Get full text